Set up immune markers still preserve their relevance for clinical decision-producing in breast cancer remedy with even prolonged meanings. Estrogen receptor (ER) stage must not only be categorized in beneficial or unfavorable. Very low ER amounts ≤10% of labeled cells needs to be dealt with in a different way (LoE 1a/A/In the past++). Tumors with